亚太地区生物製造中的病毒检测与定量市场：分析与预测（2023-2032）

亚太地区生物製造中的病毒检测和定量市场：简介

主要市场统计数据
预测期	2023-2032
2023年评估	1.1亿美元
2032年预测	2.8亿美元
复合年增长率	10.47%

亚太地区生物製造中的病毒检测和定量市场规模预计将从 2023 年的 1.1 亿美元增长到 2032 年的 2.8 亿美元，预计在预测期内复合年增长率为 10.47%。

市场的成长预计将受到生物製药使用的增加和行业病毒检测技术的进步的推动。

亚太地区生物製造病毒检测和定量市场目前正在快速发展。这一增长归因于该地区生物製药的采用增加。为了确保生物製药的安全性、有效性和一致性，对稳健的品管流程的严格需求正在推动对用于量化生技药品製造中病毒污染物的消耗品和设备的需求。随着亚太地区生物製药产业的进步，对病毒检测和定量解决方案的需求预计将激增。

本报告调查了亚太地区生物製造中病毒检测和定量的市场，并提供了市场概况、市场增长的各种影响因素分析、法律制度、市场规模趋势和预测以及主要国家的细分我们对主要企业进行了详细的分析和总结。

市场分类

细分 1：按产品类型

• 消耗品
• 装置
• 服务

细分 2：依技术分类

• PCR法
• 酵素连结免疫吸附法
• 流式细胞技术
• 斑块测定
• 其他的

细分3：按用途

• 血液及血液製品製造
• 疫苗及治疗药物製造
• 细胞/基因治疗产品製造
• 干细胞产品製造
• 纸巾和纸巾产品製造

细分 4：依最终使用者分类

• 生命科学公司
• 检测机构
• CRO 和 CDMO

细分 5：按国家/地区划分

• 中国
• 日本
• 韩国
• 澳洲
• 印度
• 其他的

目录

执行摘要

第一章 市场范围

第二章调查方法

第三章市场概况

• 概述
• 当前市场规模及未来成长潜力

第四章 行业展望

• 监管状况

第五章生物製造中的病毒检测与定量市场：市场动态

• 业务促进因素
  • 扩大生物製药的用途
  • 病毒检测和定量的技术进步
  • 影响分析
• 业务限制
  • 先进病毒检测及定量设备高成本
  • 缺乏病毒检测和定量领域训练有素的专业人员
  • 影响分析
• 商业机会
  • 在细胞和基因治疗的开发中越来越需要考虑病毒污染

第六章生物製造市场中的病毒检测和定量：按地区

• 概述
• 亚太地区
  • 按报价类型
  • 依技术
  • 按用途
  • 按最终用户
  • 按国家/地区

第七章市场：竞争基准化分析/公司简介

• 概述
• 企业市场占有率分析
• 活跃在生态系中的公司
• TAKARA HOLDINGS INC.

“The Asia-Pacific Biomanufacturing Viral Detection and Quantification Market Expected to Reach $0.28 Billion by 2032.”

Introduction to Asia-Pacific Biomanufacturing Viral Detection and Quantification Market

KEY MARKET STATISTICS
Forecast Period	2023 - 2032
2023 Evaluation	$0.11 Billion
2032 Forecast	$0.28 Billion
CAGR	10.47%

The Asia-Pacific biomanufacturing viral detection and quantification market was valued at $0.11 billion in 2023 and is anticipated to reach $0.28 billion by 2032, witnessing a CAGR of 10.47% during the forecast period 2023-2032. The biomanufacturing viral detection and quantification market growth is anticipated to be propelled by the increasing use of biopharmaceutical products and the technological advancements in viral testing within the industry.

Market Introduction

The Asia-Pacific (APAC) biomanufacturing viral detection and quantification market is currently advancing at a rapid pace. This growth can be attributed to the increasing adoption of biopharmaceuticals within the region. The stringent need for robust quality control processes to ensure the safety, efficacy, and consistency of biopharmaceutical products is driving the demand for consumables and instruments used in quantifying viral contaminants during the biomanufacturing of biologics. As APAC embraces the biopharmaceutical industry's advancements, the demand for viral detection and quantification solutions is expected to surge. This presents a significant opportunity for manufacturers and providers of biomanufacturing viral detection and quantification products in the APAC market, as they play a pivotal role in ensuring the integrity and safety of biopharmaceutical production processes in the region.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 5: by Country

• China
• Japan
• South Korea
• Australia
• India
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the APAC biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Market Scope

• 1.1. Key Questions Answered in the Report

2. Research Methodology

3. Market Overview

• 3.1. Overview
• 3.2. Current Market Size and Future Growth Potential, $Billion, 2022-2032

4. Industry Outlook

• 4.1. Regulatory Landscape
  • 4.1.1. Legal Requirements and Frameworks in Asia-Pacific
    • 4.1.1.1. Legal Requirements and Framework in Japan

5. Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

• 5.1. Business Drivers
  • 5.1.1. Increasing Utilization of Biopharmaceuticals
  • 5.1.2. Technological Advancements in Viral Detection and Quantification
  • 5.1.3. Impact Analysis
• 5.2. Business Restraints
  • 5.2.1. High Cost of Advanced Viral Detection and Quantification Equipment
  • 5.2.2. Lack of Trained Professionals in the Field of Viral Detection and Quantification
  • 5.2.3. Impact Analysis
• 5.3. Business Opportunities
  • 5.3.1. Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

6. Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

• 6.1. Overview
• 6.2. Asia-Pacific
  • 6.2.1. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 6.2.2. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 6.2.3. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 6.2.4. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 6.2.5. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 6.2.5.1. China
      • 6.2.5.1.1. China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.1.2. China Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.1.3. China Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.1.4. China Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.2. Japan
      • 6.2.5.2.1. Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.2.2. Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.2.3. Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.2.4. Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.3. India
      • 6.2.5.3.1. India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.3.2. India Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.3.3. India Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.3.4. India Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.4. Australia
      • 6.2.5.4.1. Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.4.2. Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.4.3. Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.4.4. Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.5. South Korea
      • 6.2.5.5.1. South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.5.2. South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.5.3. South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.5.4. South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.6. Rest-of-Asia-Pacific
      • 6.2.5.6.1. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.6.2. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.6.3. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.6.4. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)

7. Markets - Competitive Benchmarking & Company Profiles

• 7.1. Overview
• 7.2. Company Share Analysis
• 7.3. Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 7.4. TAKARA HOLDINGS INC.
  • 7.4.1. Company Overview
  • 7.4.2. Role of TAKARA HOLDINGS INC. in the Biomanufacturing Viral Detection and Quantification Market
  • 7.4.3. Key Competitors
  • 7.4.4. Financials
  • 7.4.5. Key Insights about the Financial Health of the Company
  • 7.4.6. Analyst Perspective

List of Figures

• Figure 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 2: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Drivers, Restraints, and Opportunities
• Figure 3: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Billion, 2022-2032
• Figure 4: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Billion, 2022-2032
• Figure 5: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Billion, 2022-2032
• Figure 6: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market: Research Methodology
• Figure 7: Primary Research Methodology
• Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 9: Top-Down Approach (Segment-Wise Analysis)
• Figure 10: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 11: Biomanufacturing Viral Detection and Quantification Market (by Region)
• Figure 12: Measures Undertaken by APAC to Enhance its Viral Testing Capacity
• Figure 13: Asia-Pacific: Market Dynamics
• Figure 14: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Billion, 2022-2032
• Figure 15: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 16: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 17: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 18: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 19: China Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 20: China Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 21: China Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 22: China Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 23: China Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 24: Japan Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 25: Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 26: Japan Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 27: Japan Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 28: Japan Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 29: India Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 30: India Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 31: India Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 32: India Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 33: India Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 34: Australia Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 35: Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 36: Australia Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 37: Australia Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 38: Australia Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 39: South Korea Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 40: South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 41: South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 42: South Korea Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 43: South Korea Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 44: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, $Million, 2022-2032
• Figure 45: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type), $Million, 2022-2032
• Figure 46: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology), $Million, 2022-2032
• Figure 47: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application), $Million, 2022-2032
• Figure 48: Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User), $Million, 2022-2032
• Figure 49: Biomanufacturing Viral Detection and Quantification Market, Total Number of Companies Profiled
• Figure 50: Biomanufacturing Viral Detection and Quantification Market, Company Share Analysis, % Share, 2022
• Figure 51: TAKARA HOLDINGS INC.: Product Portfolio
• Figure 52: TAKARA HOLDINGS INC.: Overall Financials, $Million, 2020-2022
• Figure 53: TAKARA HOLDINGS INC.: Revenue (by Region), $Million, 2020-2022
• Figure 54: TAKARA HOLDINGS INC.: R&D Expenditure, $Million, 2020-2022

List of Tables

• Table 1: Asia-Pacific Biomanufacturing Viral Detection and Quantification Market, Impact Analysis
• Table 2: Key Questions Answered in the Report
• Table 3: Methods of Virus Detection and Quantification
• Table 4: Biomanufacturing Viral Detection and Quantification Market: Regulatory Scenario
• Table 5: Technological Advancement in the Field of Viral Testing
• Table 6: Impact Analysis: Business Drivers
• Table 7: Impact Analysis: Business Restraints